Result of Everolimus Treatment on Fibrosis Progression in Maintenance Liver Transplant Patients with Recurrent Hepatitis C

被引：0
|
作者：
Villamil, F. [1 ]
Gadano, A. [2 ]
Zingale, F. [3 ]
Perez, R. [4 ]
Gil, O. [10 ]
Yantorno, S. [5 ]
Mastai, R. [6 ]
Otero, A. [7 ]
Dong, G. [8 ]
Lopez, P. [9 ]
机构：
[1] British Hosp Buenos Aires, Liver Transplant Unit, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[3] Inst Cardiovasc Rosario, Rosario, Argentina
[4] Hosp Italiano Mendoza, Mendoza, Argentina
[5] Fdn Favaloro, Buenos Aires, DF, Argentina
[6] Hosp Aleman, Buenos Aires, DF, Argentina
[7] Novartis Pharmaceut, Buenos Aires, DF, Argentina
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
[10] Hepato Gastronterol, Cordoba, Argentina
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00014
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1575
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [11] A RANDOMIZED, CONTROLLED, OPEN LABEL STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS ON FIBROSIS PROGRESSION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: THE REVERT STUDY
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R. R.
    Yantorno, S.
    Otero, A.
    Avagnina, A.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S218 - S219
  • [12] Histologic progression of recurrent hepatitis C in liver transplant allografts
    Greenson, JK
    SvobodaNewman, SM
    Merion, RM
    Frank, TS
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (06) : 731 - 738
  • [13] Progression of liver fibrosis in patients with recurrent hepatitis C after orthotopic liver transplantation.
    Teixeira, R
    Papatheodoridis, GV
    Sabin, C
    Davis, S
    Dillon, AP
    Dagher, L
    Pastacaldi, S
    Davidson, B
    Rolles, K
    Patch, D
    Burroughs, AK
    HEPATOLOGY, 2000, 32 (04) : 258A - 258A
  • [14] Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment
    Berenguer, Marina
    Schuppan, Detlef
    JOURNAL OF HEPATOLOGY, 2013, 58 (05) : 1028 - 1041
  • [15] Impact of Donor Liver Steatosis/Fibrosis Progression on Allograft Outcome in a Cohort of 203 Post Transplant Recurrent Hepatitis C Patients
    Ramineni, M.
    Moeller, M.
    Brown, K.
    Shah, V.
    LABORATORY INVESTIGATION, 2010, 90 : 370A - 370A
  • [16] Impact of Donor Liver Steatosis/Fibrosis Progression on Allograft Outcome in a Cohort of 203 Post Transplant Recurrent Hepatitis C Patients
    Ramineni, M.
    Moeller, M.
    Brown, K.
    Shah, V.
    MODERN PATHOLOGY, 2010, 23 : 370A - 370A
  • [17] Sustained Viral Response May Halt the Progression of Hepatic Fibrosis in Patients with Recurrent Hepatitis C Infection after Liver Transplant
    Esfeh, Jamak Modaresi
    Al Taii, Haider
    Hajifathalian, Kaveh
    Tonekaboni, Babak Seddigh
    Eghtesad, Bijan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S368 - S369
  • [18] Ribavirin maintenance therapy in liver transplant recipients with recurrent hepatitis C is associated with delayed disease progression.
    Tisone, G
    Palmieri, G
    Lionetti, R
    Anselmo, A
    Battista, S
    Di Paolo, D
    De Luca, L
    Manzia, T
    Orlando, G
    Angelico, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 277 - 277
  • [19] A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation
    Yilmaz, Nevin
    Shiffman, Mitchell L.
    Stravitz, R. Todd
    Sterling, Richard K.
    Luketic, Velimir A.
    Sanyal, Arun J.
    Mills, A. Scott
    Contos, Melissa J.
    Coterell, Adrian
    Maluf, Daniel
    Posner, Marc P.
    Fisher, Robert A.
    LIVER TRANSPLANTATION, 2007, 13 (07) : 975 - 983
  • [20] Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation
    Rigamonti, C.
    Donato, M. F.
    Fraquelli, M.
    Agnelli, F.
    Ronchi, G.
    Casazza, G.
    Rossi, G.
    Colombo, M.
    GUT, 2008, 57 (06) : 821 - 827
12345